
Plenary Session VIII: AATS / EACTS Evidence Session | Recorded at the AATS Mitral Conclave 2025
Plenary Session VIII: AATS / EACTS Evidence Session, recorded at the AATS Mitral Conclave 2025, provides an in-depth, evidence-based review of the 2025 ESC-EACTS Guidelines for mitral and tricuspid valve intervention. Through expert presentations and case-based discussion, this session examines key guideline recommendations, highlights areas of clinical nuance not fully addressed in written guidance and explores challenges in real-world implementation. Faculty address strategies for applying guidelines in daily practice, including patient selection, procedural decision-making, and avoidance of inappropriate indication expansion. Case examples focusing on atrial fibrillation ablation and severe primary mitral regurgitation illustrate thoughtful integration of evidence-based recommendations into individualized patient care.
Featured presentations:
- The 2025 ESC-EACTS Guidelines for Mitral and Tricuspid Intervention
- What the Guidelines Don't Say
- Applying Guidelines in Daily Clinical Practice
- Protecting Patients from Indication Creep
- Guidelines in Everyday Practice: Choosing Ablation Options for a 60-year-old Patient with Atrial Fibrillation Undergoing Mitral Valve Surgery
- Guidelines in Everyday Practice: Severe Primary Mitral Valve Regurgitation
Disclosure of Financial Relationships
The individuals in control of content for this activity did not have any relevant relationships with ACCME defined ineligible companies to disclose unless listed below. All relevant relationships were mitigated prior to the start of the activity according to The Standards for Integrity and Independence in Accredited Continuing Education.
Purpose (Desired Learning Outcome)
Following this session, learners will be able to interpret the 2025 ESC EACTS valvular heart disease guidelines and apply evidence-based recommendations appropriately in daily clinical decision making.
ACCME Accreditation Statement
The American Association for Thoracic Surgery is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
AMA Credit Designation Statement
The American Association for Thoracic Surgery designates this enduring material for a maximum of 2.25 AMA PRA Category 1 Credit (s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure of Commercial Support
The 2025 AATS International Thoracic Surgical Oncology Summit received commercial support from:
- Abbott
Available Credit
- 2.25 ABS Accredited CME
Successful completion of this CME activity, [which includes participation in the evaluation component], enables the learner to earn credit toward the CME [and Self-Assessment] requirement(s) of the American Board of Surgery Continuous Certification program. It is the CME activity provider’s responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit. - 2.25 ABTS Accredited CMESuccessful completion of this CME activity, [which includes participation in the evaluation component], enables the learner to earn credit toward the CME [and Self-Assessment / Patient Safety / Performance in Practice requirements] of the American Board of Thoracic Surgery’s Maintenance of Certification program. It is the CME activity provider’s responsibility to submit learner completion information to ACCME for the purpose of granting ABTS credit.
- 2.25 AMA PRA Category 1 Credit(s)™The American Association for Thoracic Surgery designates this for a maximum of 2.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 2.25 Participation

Facebook
X
LinkedIn
Forward